Spatial molecular profiling of a central nervous system low‐grade diffusely infiltrative tumour with INI1 deficiency featuring a high‐grade atypical teratoid/rhabdoid tumour component
暂无分享,去创建一个
[1] K. Ichimura,et al. CNS Low-grade Diffusely Infiltrative Tumors With INI1 Deficiency, Possessing a High Propensity to Progress to Secondary INI1-deficient Rhabdoid Tumors , 2020, The American journal of surgical pathology.
[2] M. Kool,et al. Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus , 2019, Neuro-oncology.
[3] Steven J. M. Jones,et al. Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration , 2019, Cell reports.
[4] A. Huang,et al. Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies , 2018, Journal of Korean Neurosurgical Society.
[5] Till Acker,et al. DNA methylation-based classification of central nervous system tumours , 2018, Nature.
[6] David T. W. Jones,et al. Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years , 2017, Journal of neuropathology and experimental neurology.
[7] C. Roberts,et al. Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies. , 2016, Neuro-oncology.
[8] Roland Eils,et al. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. , 2016, Cancer cell.
[9] Y. Xing,et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.
[10] T. Wong,et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma , 2000, Acta Neuropathologica.